A new law that took effect on Jan. 1 regulates some practices of PBMs, which act as middlemen between drug manufacturers, insurance companies and pharmacies.
PBMs have shifted away from relying on rebates, which now account for just 13% of their profits compared to 46% a decade ago. They now generate more revenue through administrative fees, many of which ...
Click in for more news from The Hill{beacon} Health Care Health Care The Big Story Congress missed a chance at PBM reforms.
From PBMs to abortion, there are plenty of health policy issues that will vie for the spotlight in 2025. For pharma marketers ...
The time is right for PBM reform, but the American people might be better served if Congress goes back to the drawing board ...
It's the latest in a series of lawsuits against Express Scripts and Optum, as pharmacy benefit managers begin to come under ...
One would cap insulin at $35 a month, and the other would regulate pharmacy benefit managers. The governor vetoed earlier ...
Wegovy and Ozempic are weight loss drugs that promise to transform the treatment of obesity, heart disease and other chronic conditions that afflict millions of Americans. But while everyone agrees ...
There’s a lot to criticize about the last-minute process that left the Massachusetts Legislature passing 110 pages of complex ...
For pharmacy benefit managers, our new Congress should focus on removing the flawed rules to improve the game rather than ...
Pharmaceutical costs only seem to go one direction—up. Why? The buzz in healthcare around rising drug costs lately is focused ...
Low-level laser therapy is a non-invasive treatment for TMJ symptoms that uses light to stimulate cellular activity, and it's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback